Integration of Myeloblastosis Associated Virus proviral sequences occurs in the vicinity of genes encoding signaling proteins and regulators of cell proliferation
- Chang Long Li†1,
- Philippe Coullin†2, 4,
- Alain Bernheim2,
- Véronique Joliot1, 5,
- Charles Auffray3, 6,
- Rima Zoroob4, 7 and
- Bernard Perbal1Email author
© Li et al; licensee BioMed Central Ltd. 2006
Received: 29 December 2005
Accepted: 10 January 2006
Published: 10 January 2006
Myeloblastosis Associated Virus type 1 (N) [MAV 1(N)] induces specifically nephroblastomas in 8–10 weeks when injected to newborn chicken. The MAV-induced nephroblastomas constitute a unique animal model of the pediatric Wilms' tumor. We have made use of three independent nephroblastomas that represent increasing tumor grades, to identify the host DNA regions in which MAV proviral sequences were integrated. METHODS Cellular sequences localized next to MAV-integration sites in the tumor DNAs were used to screen a Bacterial Artificial Chromosomes (BACs) library and isolate BACs containing about 150 kilobases of normal DNA corresponding to MAV integration regions (MIRs). These BACs were mapped on the chicken chromosomes by Fluorescent In Situ Hybridization (FISH) and used for molecular studies.
The different MAV integration sites that were conserved after tumor cell selection identify genes involved in the control of cell signaling and proliferation. Syntenic fragments in human DNA contain genes whose products have been involved in normal and pathological kidney development, and several oncogenes responsible for tumorigenesis in human.
The identification of putative target genes for MAV provides important clues for the understanding of the MAV pathogenic potential. These studies identified ADAMTS1 as a gene upregulated in MAV-induced nephroblastoma and established that ccn3/nov is not a preferential site of integration for MAV as previously thought. The present results support our hypothesis that the highly efficient and specific MAV-induced tumorigenesis results from the alteration of multiple target genes in differentiating blastemal cells, some of which are required for the progression to highly aggressive stages. This study reinforces our previous conclusions that the MAV-induced nephroblastoma constitutes an excellent model in which to characterize new potential oncogenes and tumor suppressors involved in the establishment and maintenance of tumors.
Chicken nephroblastomas induced by MAV1-N represent a unique animal model of the Wilms tumor, a kidney cancer occurring in young children at a frequency of about 1:6000 births. Early cytogenetic studies have identified multiple chromosomal alterations in Wilms tumors, raising the possibility that several steps in the differentiation pathway of blastemal cells could represent potential targets for tumorigenic events .
In an attempt to characterize genes that are altered at various stages of tumor development, we have taken advantage of the histological similarities between Wilms tumor and MAV-1(N) induced nephroblastoma.
MAV is a replication competent retrovirus which can induce nephroblastomas, osteopetrosis and lymphoid leucosis when injected in chicken . Molecular cloning of the MAV1(N) proviral genome permitted us to isolate a pure viral strain inducing specifically nephroblastomas when injected, either intravenously in ovo on embryonic day 18, or intraperitoneally in day-old chickens . The characterization of MAV sequences contained in avian nephroblastomas established that these tumors were polyclonal and that in tumor DNA, MAV was inserted at a limited number of sites, suggesting that either the integration of MAV at other sites was not associated with nephroblastoma induction, or that the selection pressure occuring naturally during tumor development had counterselected cells carrying MAV proviral genomes at other sites [1, 4].
The analysis of lambda librairies obtained from these tumors reinforced the idea that in the tumor DNA, the MAV proviral sequences were integrated at a few distinct cellular sites. The MAV genomes present in well-developed tumors were all heavily rearranged whereas in diffuse tumors of smaller size showing a less advanced tumor phenotype, the MAV genomes were full length in size and functional .
Use of junction fragments containing viral U3 and adjacent cellular sequences, permitted to establish that in one of the most developed tumor one of the proviral genome was integrated within a gene that is known as ccn3 and that we originally designated "nov" for « nephroblastoma overexpressed » .
CCN3 is one of the three founders of the CCN family of proteins which presently consists of six different members. Its expression is associated with cell quiescence [6, 7]. In normal conditions, the expression of ccn3 undergoes spatiotemporal regulation in several different tissues originating from the three germ layers, with major sites of expression being adrenal, nervous system, cartilage and bone, muscle, and kidney [7–14]. The production of CCN3 protein can be increased or decreased upon carcinogenesis [7, 12, 15–20]. In Wilms' tumors, the expression of ccn3 was a marker of differentiation  whereas in Ewings' tumors, the expression of ccn3 was associated with a higher risk of developing metastasis . In all cases, the full length CCN3 protein shows antiproliferative activity.
Albeit its expression was elevated in all avian tumors, the ccn3 gene was found to be disrupted in only one case, suggesting that either an unknown viral product, or MAV LTR enhancer was responsible for increased ccn3 expression. Indeed, it is well known that LTR enhancer sequences can activate transcription of genes localized several tens of kilobases away. However, the limited size (20 kb) of the insert DNA that was contained in the lambda recombinants, did not permit to establish whether MAV LTR sequences were present in the vicinity (at a genome scale) of the ccn3 gene in the DNA of all tumor cells.
Since we had isolated and studied tumors representing three increasing developmental stages, we took advantage of this material to ask whether the progression from an initial diffuse tumor to a well developed tumor, was accompanied by the selection of cells carrying particular MAV integration sites. To tackle this problem, we have used the BAC (bacterial artificial chromosome) and FISH (fluorescent in situ hybridization) strategies.
The results we report here confirm that a limited number of MAV-integration sites are detected in the DNA of MAV-induced nephroblastomas, with an over representation of integration sites on chromosome 2. In well-developed tumors, MAV-integration sites are localized in the vicinity of genes encoding proteins involved in matrix remodeling, angiogenesis, and signaling. Our results also indicated that ccn3 is not a common integration site in these tumors.
Materials and methods
Labeling of the BAC DNA fragments
Prior to labelling, the BAC DNA fragments were amplified by PCR using the Expand high fidelity PCR system from BOEHRINGER MANNHEIM. One hundred nanograms of insert was mixed with U and R primers (0.3 μM/L), 8 μl dNTP(10 mM), mix II buffer (10 μl), TaqE (3 U) and water to 50 μl. Amplification was performed for 30 cycles of 94°C for 30 seconds, 50°C for 1 min, 72°C for 1 min. The size of the amplified fragments were checked by electrophoresis in 1% agarose gels prior to purification with the QIAquick PCR Purification Kit (Qiagen). DNA fragments (50 ng of each) were labeled with the Amersham multiprime DNA labelling system (Amersham Pharmacia Biotech RPN161Z LIFE SCIENCE) in the conditions recommended by the supplier and purified by filtration through Sephadex G50 to remove nucleotides that were not incorporated.
Screening of the BAC library
Duplicate filters on which BAC DNA preparations had been transfered were incubated with labelled probes as described above. Colonies containing positive BACs were picked and grown at 37°C overnight into 4 μ of LB medium containing 10 μg/ml chloramphenicol. The DNA contained in pelleted cells was extracted as described above and resuspended in 40 μl of TE containing RNaseA. The DNA content of each BAC was analyzed by both Dot blotting and Southern blotting of HindIII-digested DNA.
Isolation of polyadenylated RNA from normal kidneys and nephroblastomas
Frozen tissues were homogenized with a polytron and 0.5 g of powder was resuspended in 9 ml guanidine thiocyanate buffer for purification of total RNA as previously described . Final RNA pellets were resuspended in 400 μl sterile distilled water and the concentration of each sample was determined by densitometry. To isolate polyadenylated RNA species, each sample (1 mg total RNA in 500 μl water) was mixed with 55 μl Oligitex Suspension (Qiagen) and incubated for 3 min at 70 min in a water bath. After 10 min at room temperature the Oligotex:mRNA complex was pelleted by 2 min centrifugation at 14000–18000 g and the supernatant carefully removed. The pellet was further treated as recommended by the supplier and the polyadenylated RNA fraction was collected in a final volume of 50 μl.
Labelling of polyadenylated RNA preparations
To prepare labelled RNA probes, 500 ng of each polyA-RNA preparation were mixed with 500 ng oligo dT, incubated for 10 min at 70°C and chilled on ice for 5 min. Samples were then mixed with 5 μl of 10 × PCR buffer, 5 μl of MgCl2 25 mM, 5 μl DTT 0.1 M, 2.5 μl mixture of dTTP, dATP, dGTP(10 mM each), 2.5 μl of ddTTP(1 mM), 5 μl of 32P-dCTP, and incubated for 5 min at 25°C. After addition of 1 μl of reverse transcriptase (Invitrogen) (200 U/ μl), the mix was incubated for 10 more min at 25°C and for 50 min at 42°C. The reaction was stoped by incubation at 70°C for 15 min. Each labelled preparation was purified by chromatography through a column of Sephadex G50.
Hybridization of BAC DNA filters
The blots were rinsed with 6 × SSC, and prehybridized at 68°C for 18 hours. After hybridization with labeled probe in the presence of COT I DNA the blots were washed with 2 × SSC, 0.1%SDS at 56°C for 1 hour and with: 0.1 × SSC, 0.1%SDS at 65°C for 1 more hour. Autoradiography of the dried blot was performed at -80°C.
Purification of BAC DNA fragments
To recover the DNA fragments containing sequences that encode differentially expressed RNAs, 4 μg of BAC DNA were digested with HindIII, and run in 1% low melting agarose gel. The fragments of interest were eluted by incubation at 65°C for 10 min prior to addition of 1 ml Wizard Plus resin from Promega and filtration through a minicolumn connected to vacuum manifold. The column was rinsed with washing buffer and the DNA fragments eluted with 50 μl of TE buffer.
Ligation and transformation
HindIII digested purified DNA fragment (50–100 ng) were ligated to 50 ng of dephosphorylated HindIII-digested pUC18 vector in the presence of 2.5 μl T4 ligase (Appligene) at 14°C for 18 hours. For transformation, 2 μl samples of the ligation mixture were mixed with 200 μl of DH5α competent cell. Electroporation was performed at 2.45 Kv, 25 μF, 400 Ohm. After addition of 1 ml of cold LB medium, bacteria were spread onto LB plate containing 100 μg/ml ampicillin and incubated at 37°C.
Screening of chicken cDNA libraries
A library of chicken spleen cDNA was spread on LB agar plates containing tetracycline(7.5 μg/ml) and ampiciline(12.5 μg/ml) and incubated at 37°C, overnight. The colonies were transferred to Qbiogene Neutral Membranes and replicated to LB agar plates containing tetracycline and ampiciline. The membranes were incubated successively in 0.5 N NaOH for 10 min, 0.2 N NaOH and 1.5 M NaCl for 10 min, 0.2 M TrisHCl and 2 mM EDTA for 20 seconds and 2 × SSC for 20 seconds. The filters were baked at 80°C for 2 hours prior to use for hybridization with appropriate probes.
Sequencing of positive cDNA clones
Sequencing of the cDNAs was performed with T7 universal primer and CDM8 (TAAGGTTCCTTCACAAA) primer.
Northern blot hybridization
Samples of total RNA (20 μg in 9.3 μl water) were incubated with, 20 μl deionized formamide, 6.7 μl formaldehyde, 4 μl 10 × MOPS, incubated for 5 min at 68°C, chilled on ice before loading. Formaldehyde-MOPS gels were run at 100 volts for loading and 50 volts overnight in 1 × MOPS buffer. The gel were then rinsed with DEPC-treated 20 × SSC containing 2 mercaptoethanol, transferred to Appligene positive Membranes and treated for hybridization.
Prehybridization was performed in 50% formamide, 5 × SSC, 3 x Denhardt, 0.5% SDS, 0.05 M NaH2PO4, salmon sperm DNA 100 μg/ml, at 42°C for 3 hours. Hybridization was performed in the same solution containing probes(1–3,000,000 cpm/ml). Washing of the membrane was performed in 2 × SSC, 0.2% SDS.
Cultures and chromosome preparation
Chicken (Gallus gallus) cells were obtained from 9-days-old embryos using trypsin. The cultures were incubated at 37°C or 41°C in MEM medium supplemented with 20% foetal calf serum, glutamine and penicillin/streptavidin. For cytogenetic preparations, the cells were collected using trypsin and treated with an hypotonic solution: KCL (2.8 g/l), foetal calf serum 1/12 and they were fixed with 3:1 methanol/glacial acetic acid. The same procedure was used for the other galliformes tested namely: the Common Quail (Coturnix coturnix), the Red-legged Partridge (Alectoris rufa), the Grey Peacock-Pheasant (Polyplectron bicalcaratum), the Cheer Pheasant (Catreus wallichi), the Common Pheasant, (Phasianus colchicus), the grey partidge (Perdix perdix), the turkey (Meleagris gallopavos) and the guinea-fowl (Numida melagris).
Fluorescent in situ hybridization (FISH)
The purified DNA inserts were labelled by nick translation with biotin or digoxigenin 16 dUTP (Appligene OncorR nick-translation kit, Illkirch Graffenstaden, France) according to manufacturer's instructions.
Chromosomes slides were incubated at 70°C for 2 min in 70% formamide, 2 × SSC (pH 7.2) and dehydrated in an ethanol series at 4°C. 2 μl of a 1/5 dilution of labelled probe was mixed with 6 μl of human Cot1 DNA(from a 1 mg/ml solution ; GibcoBRLR) and 32 μl of hybrisol VI (Oncor R) denatured 5 min at 80°C and incubated 30 min at 37°C before deposition on the slide. The slides were then incubated overnight at 37°C in a humidified chamber and washed three times 5 min at 42°C in 50% formamide, and in 2 × SSC at 42°C. After being rinsed in 4 × SSC at room temperature, the slides were incubated for 30 min at 37°C in blocking solution (Roche Diagnostics Meylan France). The digoxigenin was detected using an anti-digoxigenin-rhodamin-labelled antibody (Appligene OncorR) and the biotin with FITC labelled avidine (Appligene OncorR).
The slides were washed with 4 × SSC for 10 min in a shaker. After draining the excess liquid, DAPI was used as counterstain and Vectashield R (Vector laboratories Inc. Burlingame, CA 94010, USA) as antifading solution. Pictures were acquired on a Zeiss epifluorescence microscope using a tri-CCD camera and Vysis computer software (Smart capture 2). Chromosome assignments were made using reverse DAPI by reference to the GTG banded ideograms of chicken proposed by Ladjali-Mohammed et al .
The cytogenetic localization of the various BAC DNAs was performed by two independent FISH runs. For each experiment 50, and 25 cells were analyzed respectively. Except for rare cases, four chromatids per cell showed a specific signal and the percentage of triploid and tetraploid cells present in the embryonic chicken fibroblast culture was taken into account.
Human-chicken genomic comparisons
Syntenic conserved chromosome segments between human and chicken were determined from Schmid et al . Human cancer genes localized in the syntenic areas were selected from the "Atlas of Genetics and Cytogenetics in Oncology and Hematology". http://www.infobiogen.fr/services/chromcancer/. Their presence in the presumed chicken chromosome areas was investigated by data processing using different web sites (NCBI:http://www.ncbi.nlm.nih.gov, EMBL EBI : http://www.ebi.ac.uk/embl/, infobiogène : http://www.infobiogen.fr for human and NCBI, Wageningen university : http://www.zod.wau.nl/vf/ for chicken) and by calculation from the physical to the cytogenetical localisation using the relative position in the sequence and the " consensus mid-points " of the markers reported in Schmid et al .
Isolation of BACs clones harbouring genomic DNA fragments flanking the viral/cellular junctions of MAV1-related proviruses
In order to localize the various MIRs at a chromosomic scale, we have performed FISH experiments using the various BACs as probes.
Chromosome localization of BACs
The precise identification of the micro-chromosomes that gave a positive signal was not performed but co-hybridization experiments established that the four positive BACs corresponded to loci which were localized on 4 different microchromosomes (data not shown).
The strong signals obtained after hybridization of the chicken BACs with other galliform chromosomes suggested that the sequences of the MAV targets are relatively well conserved throughout the galliform order. The chromosome assigments were identical, with respect to karyotypes evolution among these birds. As an example, markers of Gga2 are scattered on two chromosomes in Castreus wallishii (data not shown).
The assignment of ccn3 on Gga 2q34-36 was already reported . To date, a series of nine genes have been assigned on chicken chromosome 2q: PRKDC (q24-25), PENK, MOS, LYN (q26), CALB1 (q26), CA2, TRHR, MYC and HSF1 of which the human homologs lie on chromosome segment 8q11-q24.1. The localization of ccn3 on human 8q24 and chicken chromosome 2q34-36 reinforced the chromosomal homology between the two species and suggested that the syntenic segment between the two species could be extended up to avian 2q3. Furthermore, the mouse ccn3 gene maps to chromosome 15  in a region of conserved synteny with man including TRHR, MYC and HSF1 .
The order of genes on the chicken map is still subject to changes. Furthermore, based on detailed analyses on other chicken chromosomes many rearrangements are known to occurr within syntenic regions. However, with the restriction regarding the order of the genes, the present findings suggest that ccn3 and AdamTS1 belong to syntenic groups well conserved between chicken, mouse and man. These genes also constitute another example where the synteny is better conserved between chicken and man than between man and mouse.
ADAMTS1 sequences are overexpressed in MAV-induced nephroblastomas
The detection of ADAMTS1 locus as a MAV integration site caught our attention because the ADAMTS1 protein belongs to a family of proteases involved in angiogeneis and tissue remodeling that are both required for tumor progression 
In order to establish whether the BACs of interest indeed contained genes differentially expressed in tumor samples, polyadenylated RNA species purified from normal kidneys and nephroblastomas, were used to probe digested BAC-DNAs.
The studies that we have performed during the past decade have allowed us to identify viral sequences responsible for the very high efficiency and restricted pathogenic potentential of MAV1-(N) [29–31]. We also established that MAV-induced nephroblastomas were polyclonal tumors  that constituted a unique model of the pediatric Wilms tumor .
The analysis of genomic libraries prepared from MAV1-induced tumors representing three different stages in tumor progression established that the MAV proviral genomes contained in the DNA of the tumor cells were not integrated in common sites. However, the relatively small size of the DNA insert transduced by the recombinant lambda phages, did not permit to exclude the possibility that MAV proviral genomes were inserted in common regions at the chromosome scale.
In order to determine whether MAV-induced rearrangements of the host genome were common to the three chicken nephroblastoma tumours that represented increasing developmental stages , we have isolated and characterized 78 BACs containing the normal DNA fragments corresponding to the insertional sites of MAV in the genome of these tumor cells. The molecular analysis of these BACs did not permit us to identify any common integration sites, but one, among the three different tumors.
It is well known that selective pressures likely occured during tumor progression and that the integration sites that we might identify at the late stages could be associated with events that led to tumor establishment. Therefore the lack of a common integration site, at a scale of 150 kb, probably reflected the various developmental stages and phenotypes of the tumors. On the other hand, our results suggested that preferential MAV integration sites might be conserved in the developed tumors, since independent junction fragments corresponding to different proviral genomes cloned from a given tumor, were hybridizing with the same BACs. These results suggested that the distribution of MAV integration sites in the tumors might not represent initial events but rather reflect the complex chromosome rearrangements that occur during tumor progression.
The use of BACs to perform a FISH analysis of the MAV integration sites permitted us to gain a better insight into the distribution of integration sites in the various tumors that we analyzed. In spite of the polyclonal nature of the nephroblastomas, a rather simple profile was obtained. The chicken genome is composed of 34 chromosomes, among which are 9 macrochromosomes and 25 microchromosomes. The MAV integration sites were found to be equally distributed between the micro and macrochromosomes that stained positive. However, these sites were not distributed randomly. Instead, the number of MAV integration site on chromosome 2 was much higher than expected and 3 integration sites were detected on this chromosome by two independent BACs. These finding suggested that during the establishment and progression of nephroblastomas, the maintenance of chromosome 2 alterations were preferentially selected. The results obtained by FISH confirmed that MAV proviral genomes were integrated in a limited number of sites, as previously predicted by junction fragment analysis  and pulse field electrophoresis .
During the preparation of this manuscript, Pajer et al. reported the use of inverse PCR and LTR-RACE to identify nephroblastoma-associated loci (Nals) in MAV2-induced avian nephroblastomas (Pajer, personal communication and manuscript in press). In order to compare the position of MAV insertion sites identified by FISH and PCR, we have calculated the physical localization of the Nals on each corresponding chromosome and found a fairly good match between the two sets of results (See additional file 1: Compilation of cytogenetic data obtained from FISH analysis). In both studies, MAV integration sites were found to be mainly distributed among chromosomes 1 and 2. Of particular interest was the identification of hot spots for proviral sequences at 1q1, and 2q2. Whether these sites represent preferential MAV integration sites or regions that contain genes required for tumor development remains an open question.
Two different types of information could be drawn from these observations: i) the distribution of MIRS and Nals points to chromosome regions that frequently harbour proviral MAV sequences in tumors; these regions likely contain genes that are important for tumor development; and ii) the reduced number of MAV integration sites that are maintained during tumor progression points to genes that are probably important at later stages, and the comparison of MAV integration sites in early and late tumors might help to distinguish between genes involved in the establishment and in the maintenance of the tumor state.
Based on the relatively well conserved synteny betwen man and chicken it was also possible to predict the nature of potential genes of interest. The use of normal and tumor RNAs as probes to identify BAC fragments that contain genes that are differentially expressed in normal and tumor tissue (figure 10) also provided critical information that could be used as another clue to assign potential genes to MAV insertion loci.
MAV integration sites were identified by FISH analysis (BACs 50, 65, 64, 97, 15) on Chromosome 2. Among the potential genes of interest contained in these areas Plag1 (8q12 in human), and twist (7p21) are target in 6% and 4% of MAV2-induced tumors (Pajer et al. In ress). Both encode transcription factors that are thought to play a role in tumorigenesis, LRCC (Leiomyomatosis and Renal Cell Cancer, 1q42-44 in human) is associated with papilloma renal cancer, while WTSL (Wilms tumor suppressor locus, 7p14-13 in human) is a potential suppressor gene whose alteration appears to be involved in normal kidney development and nephroblastoma. The CCN3/NOV gene (8q24-1 in human) which is a target for both MAV1 and MAV2-induced tumors (see below) is also localized on chromosome 2. The Gga 2 p3-2 zone represents a hot spot for MAV integration. Three BACs (85, 50 65) were mapped in this area. Bac 85 is a little more distal than the 3 others. BACs 50 and 65 are very close to each other but distinct. It is worth noting that Nal 2–28 (Pajer et al. in press) which include the twist gene overlaps with BACs 50 and 65. Our investigations also pointed out WTLS (at 7p11p15 in human) as a locus of interest for BACs 50 or 65.
Within the cytogenetic region Gga1q1 several genes of interest were potentially detected by FISH with BAC 22 and BAC 100. Among them, the cyclin-dependent kinase inhibitor 1B (CDKN 1B, 12p13 in human) and the N-ras oncogene (1p13 in human). In the same area, the data obtained by Pajer et al (in press) pointed to the POU2, OTF1, Oct1 transcription factors (1q22-3 in human). The localisation of BAC83 at Gga 1qter suggests as a potential target BIRC3 (Hsa 11q21) a candidate oncogene which is highly expressed in normal kidney and was reported to inhibit apoptosis.
At Gga3q24, the Wilms tumour 1 associated protein (WTAP, 6q25-27 in human) is a potential gene of interest for the region that is detected by two independant probes on BAC 71.
Two MAV1 insertion sites maped at 5q23-25 on the chicken genome. The human syntenic fragment (14q21-33), GPH (gephyrin at 14q23.3), TRAF3 (TNF receptor associated factor 3, at 14q32-33) and TGFβ3 (Transforming growth factor 3, at 14q24).
BACs 1 and 90 which maped at Gga 5 q23-25, contain MAV integration sites that were identified in two tumors representing different developmental stages. Both mapped very close to each other but did not co-localized since Bac1 is more proximal than Bac 90. The human syntenic fragment (14q21-33) contains several genes involved in kidney development and tumorigenesis. Among them, RCC2 (renal cell carcinoma 2, at 14q22-ter) is a locus which is lost in sporadic, non papillary renal cell carcinomas and oncocitomas. GPH (Gephyrin at 14q23.3) is a cytoplasmic, peripheral protein that anchors Gly-R. Although it is widely expressed, it is especially predominantly expressed in kidney. TRAF3 (TNF receptor associated factor 3 at 14q32-33) encodes an adapter protein that recruits other signaling molecules to the ligand-bound TNF family receptor. A gradient of TRAF3 is detected along the nephron, with progressive expression from proximal tubule to the collecting duct. TGFB3 is a well know transforming growth factor.
The region defined by BAC1 and 90 also corresponded to Nal 5–13 (Pajer et al. In press). Because these integration sites were identified in tumors representing different developmental stages, this area corresponded to a common integration region whose alteration is conserved during tumor progression, therefore suggesting that the gene(s) encoded by this portion of genome might be critical for nephroblastoma development and (or) tumor progression.
In addition to this situation, the two other integration sites identified in the most developed tumor by BACs 15 and 2 corresponded respectively to ccn3/nov (8q24.1 in human) and AdamTS1 (21q23.1 in human), two genes whose involvement in angiogenesis, matrix remodeling and tumorigenesis is well documented [7, 19–27]. The ccn3 gene was previously mapped on chicken chromosome 2q34-36 . Although the present study, and the results of Pajer et al. indicated that ccn3 is not a common integration site for MAV, this gene was identified as a MAV target in both studies. However, the MAV2-induced tumors analyzed by Pajer et al. did not show any increase in ccn3 expression.
Since both the MAV1- and the MAV2-induced nephroblastomas that we analyzed showed elevated levels of ccn3 expression , these conflicting observations result from either the route of injection, the time frame for injection, the different nature of the viral strains or host differences. The MAV2 (O) strain that was used in our previous studies was molecularly cloned and sequenced . It induced 20% nephroblastomas, as opposed to 100% efficiciency of the MAV1(N) strain. In both cases, nephroblastomas were induced after intraveinous injection of 14 day-old embryos or intraperitoneal injection of day old chicken . Since we have established that blastemal cells undergoing epithelial differentiation are the targets for MAV1, the time frame and route of injection may be critical. Indeed, the blastemal cells express high levels of ccn3 (Cherel et al. manuscript in preparation). Therefore, the elevated levels of ccn3 expression detected in all MAV-induced nephroblastomas might result from the expansion of blastemal cells that are transformed at a well defined stage of differentiation upon MAV1 infection.
Hybridization of BACs containing MAV1-integration sites with labeled mRNAs isolated from normal kidney tissue and nephroblastomas also permitted us to perform an analysis of the genes that are proximal to MAV integration sites and that are differentially expressed in normal and tumor condition. Among the different genes that were uncovered in this study, the ADAMTS1 gene was of potential interest. The ADAMTS1 protein is a matricellular proteinase known to participate in the late stages of tumorigenesis. Forty-five percent of newborn ADAMTS1 null mice died, probably as a result of kidney malformation that becomes apparent at birth .
Comparison of the expression pattern of CCN3 and ADAMTS1 shows striking similarities. In both cases overexpression of the protein is detected in all tumors tested, while the MAV proviral sequences are detected only once in the vicinity of these genes. These observations suggest that MAV -induced nephroblastoma occurs via a multistep process that involves a cascade of proteins acting along a common signaling pathway. Direct or indirect alteration of any step could result from MAV integration within or in the vicinity of critical genes whose increased expression would eventually be required for tumor progression. The identification of TGFβ 3 locus as a target for MAV integration in two independent tumors (501 and 725) is in favor of such an hypothesis. The role of TGFβ 1 in expression of CCN genes expression has been widely documented and the antagonistic activity of TGFβ 1 and TGFβ 3 has been shown to be critical in several instances. The activation of TGFβ3 expression by MAV might therefore result in an increased expression of CCN3 in tumors, similar to that observed upon integration of MAV within the ccn3 gene itself. Interestingly, tumor 725 which is the most developed is the only one in which integration of MAV occured in three gene loci whose alterations would have cummulative effects. A less developed tumor such as 501 only shows integration in the vicinity of TGFβ 3 and the early developed tumor does not show any of them.
In summary, our present study suggests that the development of nephroblastoma from an initial diffuse tumor phenotype (501D) to a well developed compact tumor (725) is accompanied by the selection of MAV integration sites in chromosome loci where genes involved in kidney differentiation are localized. The alteration of any of these genes by MAV integration at early stages of blastemal cell differentiation, would trigger the tumorigenic process. The multiplicity of potential genetic and cellular targets would provide support to the very high efficiency of MAV1 (N) which can induce 100% nephroblastomas within a 8-week period of time post injection. It will be interesting to determine whether the phenotypic variability of the MAV-induced nephroblastomas compares to the Wilms' tumors situation, and if the various subtypes of tumors result from different sequences of genes alterations.
This study was supported by funds to BP from Association pour la Recherche Contre le Cancer (ARC), Ligue Nationale Contre le Cancer (Comités du Cher et de l'Indre), and Ministère de l'Education Nationale, de la Recherche et de la Technologie. Part of this work has been achieved when the Laboratoire d'Oncologie Virale et Moléculaire was affiliated to the INSERM. Present address for PC : Endocrinologie et génétique du développement et de la reproduction INSERM U 493 92140 Clamart (France); Present address for VJ : Cellular regulations and oncogenesis-UMR 146 CNRS/Institut Curie; Present address for RZ : UPR 1983, CNRS, 7 rue Guy Moquet, 94801, Villejuif Cedex, France. CLL was recipient of a fellowship from Ligue Nationale contre le Cancer (Comité du Cher et Comité de l'Indre). We are indebted to Dr. JJ Candelier for help with data processing, Goubin SA (F22150 Plouguenast) for kindly providing chicken eggs and to A. Ardouin (IGR animal house). Thanks are due to Dr. G. Dambrine (INRA Nouzilly) for providing samples of normal chicken kidneys and to Dr. H. Yeger for critical reading of the manuscript.
- Perbal B: Contribution of MAV-1-induced nephroblastoma to the study of genes involved in human Wilms' tumor development. Crit Rev Oncog. 1994, 5 (6): 589-613.PubMed
- Perbal B: Pathogenic potential of myeloblastosis-associated viruses. Infect Agents Dis. 1995, 4 (4): 212-27.PubMed
- Perbal B, Lipsick JS, Svoboda J, Silva RF, Baluda MA: Biologically active proviral clone of myeloblastosis-associated virus type 1: implications for the genesis of avian myeloblastosis virus. J Virol. 1985, 56 (1): 240-4.PubMed CentralPubMed
- Soret J, Dambrine G, Perbal B: Induction of nephroblastoma by myeloblastosis-associated virus type 1: state of proviral DNAs in tumor cells. J Virol. 1989, 63 (4): 1803-7.PubMed CentralPubMed
- Joliot V, Martinerie C, Dambrine G, Plassiart G, Brisac M, Crochet J, Perbal B: Proviral rearrangements and overexpression of a new cellular gene (nov) in myeloblastosis-associated virus type 1-induced nephroblastomas. Mol Cell Biol. 1992, 12 (1): 10-21.PubMed CentralView ArticlePubMed
- Scholz G, Martinerie C, Perbal B, Hanafusa H: Transcriptional down regulation of the nov proto-oncogene in fibroblasts transformed by p60v-src. Mol Cell Biol. 1996, 16 (2): 481-6.PubMed CentralView ArticlePubMed
- Perbal B: NOV (nephroblastoma overexpressed) and the CCN family of genes: structural and functional issues. Mol Pathol. 2001, 54 (2): 57-79. 10.1136/mp.54.2.57.PubMed CentralView ArticlePubMed
- Su BY, Cai WQ, Zhang CG, Martinez V, Lombet A, Perbal B: The expression of ccn3 (nov) RNA and protein in the rat central nervous system is developmentally regulated. Mol Pathol. 2001, 54 (3): 184-91. 10.1136/mp.54.3.184.PubMed CentralView ArticlePubMed
- Kocialkowski S, Yeger H, Kingdom J, Perbal B, Schofield PN: Expression of the human NOV gene in first trimester fetal tissues. Anat Embryol (Berl). 2001, 203 (6): 417-27. 10.1007/s004290100177.View Article
- Perbal B, Brigstock DR, Lau LF: Report on the second international workshop on the CCN family of genes. Mol Pathol. 2003, 56 (2): 80-5. 10.1136/mp.56.2.80.PubMed CentralView ArticlePubMed
- Su BY, Cai WQ, Zhang CG, Su HC, Perbal B: A developmental study of novH gene expression in human central nervous system. C R Acad Sci III. 1998, 321 (11): 883-92.View ArticlePubMed
- Chevalier G, Yeger H, Martinerie C, Laurent M, Alami J, Schofield PN, Perbal B: novH: differential expression in developing kidney and Wilm's tumors. Am J Pathol. 1998, 152 (6): 1563-75.PubMed CentralPubMed
- Natarajan D, Andermarcher E, Schofield PN, Boulter CA: Mouse Nov gene is expressed in hypaxial musculature and cranial structures derived from neural crest cells and placodes. Dev Dyn. 2000, 219 (3): 417-25. 10.1002/1097-0177(2000)9999:9999<::AID-DVDY1058>3.0.CO;2-2.View ArticlePubMed
- Katsube K, Chuai ML, Liu YC, Kabasawa Y, Takagi M, Perbal B, Sakamoto K: The expression of chicken NOV, a member of the CCN gene family, in early stage development. Brain Res Gene Expr Patterns. 2001, 1 (1): 61-5. 10.1016/S1567-133X(01)00009-6.View ArticlePubMed
- Maillard M, Cadot B, Ball RY, Sethia K, Edwards DR, Perbal B, Tatoud R: Differential expression of the ccn3 (nov) proto-oncogene in human prostate cell lines and tissues. Mol Pathol. 2001, 54 (4): 275-80. 10.1136/mp.54.4.275.PubMed CentralView ArticlePubMed
- Glukhova L, Angevin E, Lavialle C, Cadot B, Terrier-Lacombe MJ, Perbal B, Bernheim A, Goguel AF: Patterns of specific genomic alterations associated with poor prognosis in high-grade renal cell carcinomas. Cancer Genet Cytogenet. 130 (2): 105-10. 10.1016/S0165-4608(01)00477-0. 2001 Oct 15View ArticlePubMed
- Manara MC, Perbal B, Benini S, Strammiello R, Cerisano V, Perdichizzi S, Serra M, Astolfi A, Bertoni F, Alami J, Yeger H, Picci P, Scotlandi K: The expression of ccn3(nov) gene in musculoskeletal tumors. Am J Pathol. 2002, 160 (3): 849-59.PubMed CentralView ArticlePubMed
- Perbal B: The CCN3 (NOV) cell growth regulator: a new tool for molecular medicine. Expert Rev Mol Diagn. 2003, 3 (5): 597-604. 10.1586/1473722.214.171.1247.View ArticlePubMed
- Planque N, Perbal B: A structural approach to the role of CCN (CYR61/CTGF/NOV) proteins in tumourigenesis. Cancer Cell Int. 3 (1): 15-10.1186/1475-2867-3-15. 2003 Aug 22PubMed CentralView ArticlePubMed
- Perbal B: CCN proteins: multifunctional signalling regulators. Lancet. 2004, 363 (9): 62-64. 10.1016/S0140-6736(03)15172-0.View ArticlePubMed
- Perbal B: A practical guide to molecular cloning. New York: Wiley and Sons, Second; 1988.
- Ladjali-Mohammedi K, Bitgood JJ, Tixier-Boichard M, Ponce De Leon FA: International system for standardized avian karyotypes (ISSAK): standardized banded karyotypes of the domestic fowl (Gallus domesticus). Cytogenet Cell Genet. 1999, 86 (3–4): 271-6. 10.1159/000015318.View ArticlePubMed
- Schmid M, Nanda I, Guttenbach M, Steinlein C, Hoehn M, Schartl M, Haaf T, Weigend S, Fries R, Buerstedde JM, Wimmers K, Burt DW, Smith J, A'Hara S, Law A, Griffin DK, Bumstead N, Kaufman J, Thomson PA, Burke T, Groenen MA, Crooijmans RP, Vignal A, Fillon V, Morisson M, Pitel F, Tixier-Boichard M, Ladjali-Mohammedi K, Hillel J, Maki-Tanila A, Cheng HH, Delany ME, Burnside J, Mizuno S: First report on chicken genes and chromosomes 2000. Cytogenet Cell Genet. 2000, 90 (3–4): 169-218. 10.1159/000056772.View ArticlePubMed
- Pajer P, Pecenka V, Karafiat V, Kralova J, Horejsi Z, Dvorak M: The twist gene is a common target of retroviral integration and transcriptional deregulation in experimental nephroblastoma. Oncogene. 22 (5): 665-73. 10.1038/sj.onc.1206105. 2003 Feb 6View ArticlePubMed
- Iruela-Arispe ML, Carpizo D, Luque A: ADAMTS1: a matrix metalloprotease with angioinhibitory properties. Ann N Y Acad Sci. 2003, 995: 183-90.View ArticlePubMed
- Tang BL: ADAMTS: a novel family of extracellular matrix proteases. Int J Biochem Cell Biol. 2001, 33 (1): 33-44. 10.1016/S1357-2725(00)00061-3.View ArticlePubMed
- Carpizo D, Iruela-Arispe ML: Endogenous regulators of angiogenesis – emphasis on proteins with thrombospondin – type I motifs. Cancer Metastasis Rev. 2000, 19 (1–2): 159-65. 10.1023/A:1026570331022.View ArticlePubMed
- Coullin P, Li CL, Ziercher L, Auffray C, Bernheim A, Zoorob R, Perbal B: Assignment of the chicken NOV gene (alias CCN3) to chromosome 2q34 – >q36: Conserved and compared synteny between avian, mouse and human. Cytogenet Genome Res. 2002, 97 (1–2): 140c-10.1159/000064046.View ArticlePubMed
- Joliot V, Boroughs K, Lasserre F, Crochet J, Dambrine G, Smith RE, Perbal B: Pathogenic potential of myeloblastosis-associated virus: implication of env proteins for osteopetrosis induction. Virology. 1993, 195 (2): 812-9. 10.1006/viro.1993.1436.View ArticlePubMed
- Joliot V, Khelifi C, Wyers M, Dambrine G, Lasserre F, Lemercier P, Perbal B: The noncoding and surface envelope coding sequences of myeloblastosis-associated virus are respectively responsible for nephroblastoma development and renal hyperplasia. J Virol. 1996, 70 (4): 2576-80.PubMed CentralPubMed
- Khelifi-Younes C, Dambrine G, Cherel Y, Soubieux D, Li CL, Perbal B: Deletions within the U3 long terminal repeat alter the tumorigenic potential of myeloblastosis associated virus type 1(N). Virology. 316 (1): 84-9. 10.1016/j.virol.2003.07.005. 2003 Nov 10View ArticlePubMed
- Kuno K, Liszasa H, Ohno S, Matsushima K: the exon/intron organization and chromosomal mapping of the mouse ADAMTS-1 gene encoding an ADAM family with TSP motifs. Genomics. 1997, 46: 466-71. 10.1006/geno.1997.5064.View ArticlePubMed
- Snaith MR, Natarajan D, Taylor LB, Choi CP, Martinerie C, Perbal B, Schofield PN, Boulter CA: Genomic structure and chromosomal mapping of the mouse nov gene. Genomics. 1996, 38 (3): 425-8. 10.1006/geno.1996.0647.View ArticlePubMed
- Mittaz L, Russell DL, Wilson T, Brasted M, Tkalcevic J, Salamonsen LA, Hertzog PJ, Pritchard MA: Adamts-1 is essential for the development and function of the urogenital system. Biol Reprod. 2004, 70: 1096-1105. 10.1095/biolreprod.103.023911.View ArticlePubMed
This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.